Skip to main content
Figure 8 | Diabetology & Metabolic Syndrome

Figure 8

From: CNX-013-B2, a unique pan tissue acting rexinoid, modulates several nuclear receptors and controls multiple risk factors of the metabolic syndrome without risk of hypertriglyceridemia, hepatomegaly and body weight gain in animal models

Figure 8

Gene expression in ob/ob mice after 4 weeks of treatment with CNX-013-B2. mRNA expression levels of multiple genes from (A) Liver, ( B ) Adipose and (C) Muscle were analyzed at the end of the study as mentioned in Materials and methods. All the values are expressed as Mean ± SEM. Statistical comparison between control and treatment group was conducted by unpaired Student’s t test. P value significance was represented as (*) <0.05, (**) <0.01 and (***) <0.001.

Back to article page

Diabetology & Metabolic Syndrome

ISSN: 1758-5996

Contact us